COTI-2 reactivates mutant p53 and inhibits growth of triple-negative breast cancer cells

被引：0
|
作者：
Naoise C. Synnott
David O’Connell
John Crown
Michael J. Duffy
机构：
[1] University College Dublin,UCD School of Medicine, Conway Institute of Biomolecular and Biomedical Research
[2] University College Dublin,UCD School of Biomolecular & Biomedical Science
[3] St. Vincent’s University Hospital,Department of Medical Oncology
[4] St. Vincent’s University Hospital,UCD Clinical Research Centre
来源：
Breast Cancer Research and Treatment | 2020年 / 179卷
关键词：
p53; TP53; COTI-2; Triple-negative breast cancer; Treatment; APR-246;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：47 / 56
页数：9
相关论文
共 50 条
  • [1] COTI-2 reactivates mutant p53 and inhibits growth of triple-negative breast cancer cells
    Synnott, Naoise C.
    O'Connell, David
    Crown, John
    Duffy, Michael J.
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 179 (01) : 47 - 56
  • [2] Degradation of MYC by the mutant p53 reactivator drug, COTI-2 in breast cancer cells
    Minhong Tang
    John Crown
    Michael J Duffy
    Investigational New Drugs, 2023, 41 : 541 - 550
  • [3] Degradation of MYC by the mutant p53 reactivator drug, COTI-2 in breast cancer cells
    Tang, Minhong
    Crown, John
    Duffy, Michael J.
    INVESTIGATIONAL NEW DRUGS, 2023, 41 (4) : 541 - 550
  • [4] Role of Reactivating Mutant p53 Protein in Suppressing Growth and Metastasis of Triple-Negative Breast Cancer
    Berke, Taylor P.
    Slight, Simon H.
    Hyder, Salman M.
    ONCOTARGETS AND THERAPY, 2022, 15 : 23 - 30
  • [5] Mutant p53: a novel target for the treatment of patients with triple-negative breast cancer?
    Synnott, N. C.
    Murray, A.
    McGowan, P. M.
    Kiely, M.
    Kiely, P. A.
    O'Donovan, N.
    O'Connor, D. P.
    Gallagher, W. M.
    Crown, J.
    Duffy, M. J.
    INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (01) : 234 - 246
  • [6] ERβ decreases the invasiveness of triple-negative breast cancer cells by regulating mutant p53 oncogenic function
    Bado, Igor
    Nikolos, Fotis
    Rajapaksa, Gayani
    Gustafsson, Jan-Ake
    Thomas, Christoforos
    ONCOTARGET, 2016, 7 (12) : 13599 - 13611
  • [7] p53 as a Specific Prognostic Factor in Triple-negative Breast Cancer
    Chae, Byung Joo
    Bae, Ja Seong
    Lee, Ahwon
    Park, Woo Chan
    Seo, Young Jin
    Song, Byung Joo
    Kim, Jung Soo
    Jung, Sang Seol
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2009, 39 (04) : 217 - 224
  • [8] Eupaformosanin induces apoptosis and ferroptosis through ubiquitination of mutant p53 in triple-negative breast cancer
    Wei, Yingying
    Zhu, Zhihui
    Hu, Hongtao
    Guan, Jiaqi
    Yang, Bo
    Zhao, Huajun
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 924
  • [9] Differences in prognosis and efficacy of chemotherapy by p53 expression in triple-negative breast cancer
    Soo Youn Bae
    Seok Jin Nam
    Yongsik Jung
    Sae Byul Lee
    Byung-Woo Park
    Woosung Lim
    Sung Hoo Jung
    Hsien Wen Yang
    Seung Pil Jung
    Breast Cancer Research and Treatment, 2018, 172 : 437 - 444
  • [10] Differences in prognosis and efficacy of chemotherapy by p53 expression in triple-negative breast cancer
    Bae, Soo Youn
    Nam, Seok Jin
    Jung, Yongsik
    Lee, Sae Byul
    Park, Byung-Woo
    Lim, Woosung
    Jung, Sung Hoo
    Yang, Hsien Wen
    Jung, Seung Pil
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 172 (02) : 437 - 444
12345